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Summary
The molecular mechanisms of exon definition and back-splicing are fundamental unanswered 
questions in pre-mRNA splicing. Here we report cryoEM structures of the yeast E complex 
assembled on introns, providing the first view of the earliest event in the splicing cycle that 
commits pre-mRNAs to splicing. The E complex architecture suggests that the same spliceosome 
can assemble across an exon, which either remodels to span an intron for canonical linear splicing 
(typically on short exons) or catalyzes back-splicing generating circRNA (on long exons). The 
model is supported by our experiments demonstrating that E complex assembled on the yeast 
EFM5 or HMRA1 middle exon can be chased into circRNA when the exon is sufficiently long. 
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This simple model unifies intron definition, exon definition, and back-splicing through the same 
spliceosome in all eukaryotes and should inspire experiments in many other systems to understand 
the mechanism and regulation of these processes.
The spliceosome forms sequentially the E, A, Pre-B, B, Bact, B*, C, C*, P, and ILS 
complexes through the splicing cycle. CryoEM structures of all but one S. cerevisiae (yeast) 
spliceosomal complexes 1,2 provided valuable information on later stages of the splicing 
cycle. There is, however, a lack of structural and mechanistic understanding of the E 
complex formation, the earliest event that initiates the splicing cycle. Thus, how the splicing 
machinery accurately defines introns and exons remains a fundamental unanswered 
question. In yeast which typically contain small introns and large exons, intron definition, 
where the spliceosome initially recognizes and assembles across an intron, seems to 
dominate 3. On the other hand, exon definition 4 prevails in vertebrate, where small exons 
and large introns are prevalent. In the exon definition model, the spliceosome recognizes and 
assembles across an exon first. However, in order to splice out introns, it was assumed that 
the exon definition complex (EDC) needs to be remodeled to a cross-intron complex. 
Support for the exon definition model is largely circumstantial, and biochemical and 
structural analyses of the exon definition process are limited. Although the EDC seems to be 
similar to the intron definition complex (IDC) in composition 5,6, we do not know if the two 
complexes differ in their structural organization and how an EDC remodels to span an 
intron.
In addition to canonical splicing, a peculiar back-splicing reaction generates a class of 
circular RNAs (circRNAs) observed in diverse eukaryotic species, prompting the speculation 
that back-splicing is also an ancient and conserved feature of eukaryotic gene expression 
pathway 7. CircRNAs play roles in the regulation of their host genes or microRNAs, aging, 
and other disease processes 8. Although canonical splicing signals and spliceosome are 
needed for circRNA production 9, the exact players and mechanism of back-splicing remain 
unknown.
To fill these gaps, we set out to obtain molecular details of the earliest step of the yeast 
splicing cycle that commits a pre-mRNA to splicing. In yeast, intron recognition is initiated 
by the binding of U1 snRNP on the 5’ splice site (ss) 10-12, and the recognition of the branch 
point sequence (BPS) by the BBP and Mud2 heterodimer (the 3’ ss is not recognized until 
much later), forming the E complex (also referred to as the CC2 complex) 13. Here we report 
the cryoEM structure of the yeast E complex assembled on either the Act1 pre-mRNA or the 
Ubc4 pre-mRNA. These structures and subsequent biochemical analyses reveal a unified 
mechanism for intron definition, exon definition and remodeling, and back-splicing-
mediated circRNA biogenesis.
In vitro assembled E complex is functional
After discovering that E complex purified from yeast is too heterogenous for structural 
determination, we assembled the E complex in vitro using uncapped 3xMS2-Act1 pre-
mRNA (M3-Act1) and purified U1 snRNP, BBP and Mud2 proteins (referred to as the Act1 
complex). The complex was purified sequentially by the MS2 tag and the CBP tag on U1A 
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and Mud2. After RNase H cleavage of M3-Act1 into two fragments (Extended Data Fig. 1a-
b), the MS2 tag still pulled down all U1 snRNP proteins, BBP, and Mud2 (Fig. 1a), 
confirming that U1 snRNP and BBP/Mud2 interact instead of being simply tethered through 
M3-Act1. In addition, the assembled Act1 complex can be chased into spliced M3-Act1 in 
U1 snRNA depleted yeast extract (Fig. 1b, lane 5). Although excess Act1-3xMS2 pre-
mRNA (Act1-M3) can effectively compete with free M3-Act1 for splicing (Fig. 1b, lane 2), 
it cannot compete with assembled Act1 complex (Fig. 1b, lane 6). These data indicate that 
our assembled E complex has not fallen apart significantly in the splicing extract and is 
functional.
5’ ss recognition is facilitated by proteins and RNA secondary structures
We determined the cryoEM structure of the Act1 complex to 3.2 Å resolution (Extended 
Data Fig. 2-4, Extended Data Table 1). After observing low resolutions in several key areas, 
we also assembled the E complex on a capped Ubc4 pre-mRNA, crosslinked the complex 
with BS3, and determined its structure to 3.6 Å resolution. The overall structures of the two 
complexes are similar (Extended Data Fig. 5a) and subsequent discussions refer to their 
common features unless otherwise stated.
In these structures, the 5’ ss basepairs with the 5’ end of U1 snRNA (Fig. 2a-b), which is 
stabilized by U1C and Luc7 proteins, similar to that observed in the yeast A and pre-B 
structures 14,15. In addition, a homology model of the yeast nuclear cap binding protein 
(NCBP) complex can be fitted as a rigid body into the density upstream of nucleotide −9 of 
Ubc4 (Fig. 2c), likely binding to the pre-mRNA cap. The RRM domain of U1-70K is shifted 
toward NCBP in the Ubc4 complex compared to the uncapped Act1 complex (Extended 
Data Fig. 5a), suggesting that NCBP directly interacts with U1-70K RRM and providing a 
possible mechanism by which NCBP recruits U1 snRNP and facilitates splicing of cap-
proximal introns 16,17. In both complexes, the RRM2 domain of Nam8 is positioned to bind 
to the intronic region immediately downstream of nt +13 (Fig. 2c), illustrating the structural 
basis of Nam8’s role in facilitating 5’ ss recognition 18.
A striking feature in the Act1 complex is a ~25bp double helix on a binding surface formed 
by many positively charged residues on the C-terminal tail of Prp39 and the N-terminal 
domain of Prp42, as well as the C-terminal domain of U1C (Fig. 2d). Such double helix 
density is also observed in the Pre-B complex structure and is tentatively modeled as part of 
U2 snRNA 15. Our Act1 complex is in vitro assembled and contains no U2 snRNA 
(Extended Data Fig. 5b). Furthermore, no such double helix exists in the Ubc4 complex, 
supporting that this helix is part of the Act1 pre-mRNA. Although we were unable to model 
specific nucleotides, a weak density connects this helix to the 5’ ss, suggesting that it 
belongs to the region downstream of the 5’ ss. The 5’ ss to BPS region (265nt) of the Act1 
intron is predicted to form long stem-like structures, while the same region in Ubc4 (58nt) 
contains a much shorter possible secondary structure (Extended Data Fig. 6a), potentially 
explaining why a stem-like structure is observed in the Act1 but not the Ubc4 complex. 
Mutation of this region in the Act1-Cup1 reporter 19 that abolishes extensive secondary 
structures (Extended Data Fig. 6b) leads to significant pre-mRNA accumulation compared to 
the WT (Fig. 2e), suggesting that this secondary structure facilitates splicing. Our structures 
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of the E and P complexes 20 therefore provided direct evidence that the intronic regions of 
pre-mRNA can form highly ordered secondary structures, which may help bring key intronic 
elements close together and whose direct interaction with proteins may also facilitate 
spliceosomal assembly.
The 5’ ss and BPS are bridged by intrinsically flexible Prp40
A critical event in the first step of the splicing cycle is to define the intron by bringing 
together the 5’ ss and BPS in which U1 snRNP protein Prp40 seems to be a key player 13. 
Prp40 contains two N-terminal WW domains, a ~60-residue linker, and six C-terminal FF 
domains. In the region between U1-70K and Luc7 in the Ubc4 complex structure, there is a 
boomerang-shaped density that matches well with the crystal structures of tandem FF 
domains connected by long helices 21,22 (Fig. 2f, Extended Data Fig. 4g). (This density is 
not obvious in the Act1 complex, possibly because the Act1 complex is not cross-linked 
with BS3.) There is weak density connecting the boomerang-shaped density and U1-70K 
(Fig. 2f), and the C-terminal FF domains crosslinks to U1-70K in the Ubc4 complex (while 
the N-terminal and middle FF domains crosslink to Luc7 and Snu71) (Extended Data Fig. 
7a). These observations led us to assign the boomerang-shaped density as the Prp40 FF4-6 
domains (although we cannot rule out the possibility of this density being the other tandem 
FF domains such as FF3-5), which is also consistent with our observation that Prp40 FF1-3 
domain interacts with Luc7 (Extended Data Fig. 7b).
Prior biochemical analyses have shown that Prp40 forms a stable dimer with Snu71 and a 
trimer with Snu71-Luc7 23-25, and the Prp40 WW domains directly interact with the N-
terminal domain of BBP 13,26. BBP also forms non-exclusive interactions with both Prp40 
and Mud2 13, and BBP directly binds to the BPS of pre-mRNA 27. In the Act1 complex 
structure, there is a large volume of weak density close to the pre-mRNA double helix 
(Extended Data Fig. 4j). The density can be best interpreted as the BBP/Mud2 dimer for 
three reasons: Its location corresponds roughly to where U2 SnRNP is in the A complex 
structure 14 (Extended Data Fig. 4j); crosslinking and mass spectrometry analyses indicate 
that BBP/Mud2 is located in this region (Extended Data Fig. 7a); BBP/Mud2 are the only 
proteins left in the E complex that are large enough to fill the volume of this density. This 
density is not obvious in the Ubc4 complex structure, potentially because Ubc4 lacks the 
pre-mRNA helix that brings the BPS close to the 5’ ss. Prp40 therefore bridges both ends of 
the intron by interacting with U1-70K and Snu71-Luc7 of U1 snRNP through its FF 
domains, and interacting with BBP through its WW domains. The entire ~60-residue linker 
region between the WW and FF domains is predicted to be disordered (Extended Data Fig. 
7c), explaining why density corresponding to BBP/Mud2 is difficult to observe.
Exon definition occurs in yeast
The E complex architecture, in particular the relative positions between the 5’ ss and the 
BPS where BBP binds, suggests that the same E complex can form across an exon. Instead 
of connecting the upstream 5’ ss to a downstream BPS through an intron (Fig. 3a), the BPS 
can be connected to a downstream 5’ ss through an exon (Fig. 3b). Similarly, the A complex 
structure 14 suggests that the same A complex could also form across exons (Fig. 3b). 
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Modeling using Rosetta RNP-denovo method 28 suggests that only 28nt between the 
upstream BP and downstream 5’ ss is needed to span the U2 snRNP and U1 snRNP in the A 
complex (Extended Data Fig. 8a). The minimal distance connecting the same BP and 5’ ss is 
likely similar or smaller in the E complex, given the similar spatial position and smaller size 
of BBP/Mud2 compared to U2 snRNP (Extended Data Fig. 4j). On the other hand, adding 
the tri-snRNP to form the pre-B complex forces an ~30° increase in the angle between U1 
snRNP and U2 SF3b 14,15 (Fig. 3b). A relatively short exon may hinder this conformational 
change and also create steric hindrance for the addition of the bulky tri-snRNP (Fig. 3b). 
This may signal to the spliceosome that an EDC has formed and provide an opportunity for 
the upstream 5’ ss to interact with the tri-snRNP to form an intron-spanning B complex (Fig. 
3b). We use EDC to refer to spliceosomal complexes assembled across an exon, which can 
be an exon-defined E, A, or unstable pre-B complex.
To test whether the E complex can form across a yeast exon, we truncated the multi-intronic 
DYN2 gene to only contain its middle exon and partial flanking introns (Dyn2 IEI, Extended 
Data Fig. 8b). Spliceosomal complexes assemble on either Dyn2 WT or IEI pre-mRNAs 
(using the same protocol as the Act1 complex) contain the same protein components in 
similar quantities, even after RNase H cleavage between the BPS and 5’ ss (Extended Data 
Fig. 8c-e). Furthermore, 2D classifications of negative-stain images of the Dyn2 IEI 
complex resemble those of the Act1 and Ubc4 complexes (Extended Data Fig. 8f). These 
observations support the formation of E complex across the Dyn2 middle exon in vitro.
We next asked whether exon-definition occurs in vivo in yeast, by evaluating whether 
mutation of splice sites bordering the Dyn2 middle exon negatively affect splicing of both 
flanking introns, a hallmark used to support the exon definition model in vertebrates 4. We 
generated a BPS mutation in intron 1 (I1-BP mutant), a 5’ ss mutation in intron 2 (I2-5’ss 
mutant), and a double mutation on DYN2 gene (Extended Data Fig. 8b). We demonstrated 
that the I2-5’ ss and I1-BP mutations impaired the splicing of intron 1 and intron 2, 
respectively (Fig. 4a). We further evaluated the splicing products of WT and each mutant 
using PCR and primers located in exons 1 and 3 (Fig. 4b). If Dyn2 splicing is solely 
governed by intron definition, we would observe retention of the intron where these 
mutations reside (with minimal effect on the distal intron), generating products containing a 
single intron (255 and 271bp bands). On the other hand, if Dyn2 splicing is solely governed 
by exon definition, the mutations would lead to the retention of both introns (i.e., 
accumulation of the 351bp pre-mRNA band) or exon skipping (the 152bp band), but not any 
product containing a single intron (indicating that the distal intron was successfully spliced). 
The fact that we observed both pre-mRNA accumulation and single-intron-containing 
products (Fig. 4b, lanes 4 and 5) suggest that both intron definition and exon definition 
contribute to Dyn2 splicing in vivo. We observed exon skipping for the I1-BP mutant but not 
the I2-5’ ss mutant, consistent with previous observations 29. This observation differs from 
that in the mammalian system where exon definition mutation leads to predominantly exon 
skipping, likely because intron definition also contributes to Dyn2 splicing, leading to co-
transcriptional splicing of intron 1 in I2-5’ ss mutant which prevents exon skipping 29. Taken 
together, our results demonstrate that exon definition occurs for a fraction of the Dyn2 
transcripts in vivo in yeast.
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The EDC catalyzes back-splicing on long exons
An intriguing prediction of our exon definition model is that if the exon connecting the BP 
and downstream 5’ ss is long enough, it will not create much steric hindrance and will allow 
tri-snRNP to join the pre-B complex and complete the rest of the splicing cycle (Fig. 3c). As 
a result, the 5’ ss downstream of the exon will be back-spliced to the upstream 3’ ss, 
generating a circRNA through the same transesterification reaction used by canonical 
splicing (Fig. 3d). Supporting this hypothesis, 7 of the 10 multi-intron genes in S. cerevisiae 
form circRNA products 7.
To test this model, we purified yeast spliceosome using TAP-tagged Cef1 (a strategy used to 
purify and determine the cryoEM structures of multiple spliceosomal complexes) from the 
Prp22H606A mutant strain defective in exon release 30. As expected, purified spliceosomes 
contained spliced mRNA and lariat for yeast single-intronic gene RPP1B, as well as the 
unique T-branch and circRNA for multi-intronic genes EFM5 and HMRA1 (Fig. 5a, 
Extended Data Fig. 9a). These results establish that Cef1-purified spliceosome contains both 
canonical and back-splicing products.
Further supporting this model (Fig. 3c-d), we showed using RT-PCR that the EFM5 IEI 
construct on an expression plasmid generated a RNase R-resistant circRNA corresponding to 
exon 2 in vivo (Fig. 5b, lane 10, Extended Data Fig. 9b). Mutating the BPS or 5’ ss or 
shortening exon 2 to 63 nt abolishes circRNA formation (Fig. 5b, lanes 11, 12, and 14). E 
complex assembled on in vitro transcribed EFM5 IEI-101-M3 (exon 2 shortened to 101nt 
and 3xMS2 at the 3’ end) (Extended Data Fig. 9c) can be chased into circRNA in U1-
depleted yeast extract in the presence of excess competing IEI-101 RNA (Fig. 5c). To ensure 
the generality of our observation, we carried out the same experiments using another yeast 
multi-intronic gene HMRA1 and obtained the same conclusion (Extended Data Fig. 9d-e). 
Taken together, these results support that exon definition occurs in yeast across the EFM5 or 
HMRA1 middle exon, which catalyzes back-splicing and generates circRNA when this exon 
is sufficiently long.
Discussion
It was previously unclear whether the EDC is the same or different from the IDC. The 
architecture of the E complex makes it immediately apparent that the same complex can 
form across either intron or exon without the need of additional components or structural 
rearrangement, and the same can be deduced for the A complex. The structures of the E and 
A complexes predict a minimal BP to 5’ ss distance (28nt for the A complex and likely a 
similar or smaller number for the E complex) in order for exon definition to occur. An exon 
that is above this minimum but still relatively short potentially makes it difficult for tri-
snRNP to join the spliceosome. This leads to the spliceosome to stall at the pre-B stage and 
fail to handoff the 5’ ss from U1 to U6, providing an opportune point for the spliceosome to 
remodel into an intron-spanning B complex involving the upstream 5’ ss. This model is 
consistent with the observation in mammalian systems where tri-snRNP is loosely 
associated with the EDC, and only becomes stably associated when a 5’ss-containing RNA 
oligo is added and the EDC is converted to a B-like intron-spanning complex 6. Supporting 
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our exon definition model, we showed that intron definition and exon definition both 
contribute to yeast Dyn2 splicing in vivo (Fig. 4). Although yeast has few multi-intronic 
genes and exon definition is clearly not the driving force of splicing, our results provide the 
proof of principle evidence that both intron and exon definition can occur through the same 
spliceosomal structure in most or all species, even on the same pre-mRNA. Whether intron 
or exon definition is dominant in vivo is likely determined by gene architecture (such as the 
length of introns or exons) and other factors (such as exonic or intronic enhancers or 
suppressors and their associated proteins, RNA secondary structures, transcription 
processivity, and nucleosome positioning, etc).
CircRNA generated by back-splicing of exons has attracted increasing attention, but its 
origin and biogenesis have largely remained a mystery 8. Although exon definition was 
speculated to play a role in back-splicing 31,32, it is unclear which of the canonical 
spliceosomal components are required and what exact signals are being recognized that 
makes an exon forming circRNA instead of participating in canonical splicing. Our results 
demonstrate that back-splicing is catalyzed by exon-definition complexes on long exons (or 
multiple exons) not remodeled to intron-spanning complexes, suggesting that circRNA is a 
natural byproduct of spliceosome-mediated splicing in all eukaryotic species. This model is 
consistent with what was envisioned by the Wilusz group based on competition between 
back-splicing and canonical splicing 31 and with previous observation that long but not short 
exon (when flanked by the same intronic sequences) can form circRNAs in human cells 33. 
Indeed, the average exon length in circRNA is 690 nt 34, much longer than the median 
length of 120 nt for human exons 35. The long exon inevitably lowers the efficiency of initial 
exon-definition, contributing to the low frequency of back-splicing and circRNA production. 
Intronic complementary sequences flanking the exon and RNA-binding proteins potentially 
increase the efficiency of initial exon-definition and facilitate circRNA production 8. These 
RNA elements or proteins may also bring opposite ends of different exons close together for 
back-splicing, generating circRNAs containing multiple exons. It is worth noting that, 
accurately speaking, the distance between the upstream BP and downstream 5’ ss across an 
exon instead of the exon length in yeast pre-mRNAs determines the fate of the EDC, since 
the 3’ ss is not recognized in early yeast spliceosomes. However, given the generally short 
distance between yeast BP and 3’ ss (19 nt for EFM5 and 10 nt for HMRA1 intron 1) 36, 
exon lengths ultimately play a major role in determining the outcome of EDC remodeling.
In summary, our E complex structure enabled us to propose a simple model that unifies 
intron definition, exon definition, and back-splicing, without needing a different spliceosome 
for each process. This model is supported by our biochemical analyses performed 
exclusively in yeast which is now positioned to serve as a well-defined model system to 
understand exon definition or back-splicing. This model likely holds true for all eukaryotes, 
although many cis or trans factors (including RNA, protein, transcription, nucleosome, etc.) 
may act as modulators to promote or suppress a particular process. In vertebrate, most exons 
are short which is likely the main signal for EDC remodeling, but other factors may facilitate 
remodeling of EDC assembled on long exons and lower the efficiency of back-splicing. This 
model should inspire experiments in many other systems to understand the mechanism and 
regulation of exon definition and back-splicing, some of the most fundamental unanswered 
questions in pre-mRNA splicing.
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Methods
Yeast E complex assembly and purification
The coding regions of yeast BBP and Mud2 were amplified by PCR using genomic S. 
cerevisiae DNA as templates. BBP fused to an N-terminal protein A (protA) tag was inserted 
between a GPD promoter and a CYC1 terminator, and the resulting expression cassette was 
cloned into pRS414 to generate the pRS414/GPD-protA-BBP plasmid. Similarly, Mud2 
with or without a C-terminal Calmodulin Binding Peptide (CBP) tag was cloned into 
pRS416 vectors to generate the pRS416/GPD-Mud2-CBP or pRS416/GPD-Mud2 plasmid. 
Six liters of BCY123 cells harboring both plasmids were grown in -URA-TRP selective 
media to OD600=3-4. The cells were flash-frozen in liquid nitrogen to form yeast 
“popcorns” and cryogenically ground using a SPEX 6870 Freezer/Mill. The frozen cell 
powder was thawed at room temperature and re-suspended in lysis buffer (50 mM Tris-HCl, 
pH 8.0, 400 mM NaCl, 0.1% NP-40, 1mM DTT) with protease inhibitor cocktails (Sigma-
Aldrich) and 1 mM Benzamidine. The cell lysate was first centrifuged at 27,485 × g for 1 hr 
in a GSA rotor (Sorvall) and the supernatant was further centrifuged at 167,424 × g in a 45Ti 
rotor (Beckman) for 1.5 hr at 4°C. The supernatant was incubated with 2 ml of IgG 
Sepharose-6 Fast Flow resin (GE Healthcare) overnight at 4°C. The resin was first washed 
with IgG washing buffer (20 mM Tris-HCl, pH 8.0, 350 mM NaCl, 0.05% NP-40, 0.5 mM 
DTT, 1 mM Benzamidine and protease inhibitor cocktails), then with buffer containing 250 
mM and 150 mM NaCl. The BBP/Mud2 dimer was released by TEV protease in TEV150 
buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.02% NP-40, 0.5 mM DTT).
The Act1 pre-mRNA used in this paper is consisted of a 73 nt 5′ exon, the 302 nt intron that 
lacks a cryptic branch point sequence, and a 167 nt 3′ exon 37. The Ubc4 pre-mRNA is 
consisted of a 20 nt 5′ exon, a 95 nt intron, and a 32 nt 3′ exon 38. The Dyn2 wildtype pre-
mRNA is consisted of three exons (22 nt, 23 nt, and 35 nt in lengths) which are separated by 
two introns (96 nt and 80 nt in lengths). The Dyn2 Intron-Exon-Intron (IEI) pre-mRNA is 
consisted of intron 1 without the first 9 nt, the middle exon, and intron 2 truncated right 
before the branch point sequence. The EFM5 IEI-101 pre-mRNA is consisted of intron 1 
without the first 10 nt, the middle exon shortened to 101 nt, and intron 2 truncated to 9 nt 
upstream of the BPS. The HMRA1 IEI-246 wild type pre-mRNA is consisted of intron 1 
without the first 10 nt, the entire middle exon, and intron 2 truncated to 2 nt upstream of the 
BPS. The HMRA1 IEI-246 pre-mRNA was generated after mutating the underlined part of 
the last 41 nt of its middle exon from 5’-
CAAAGAAATGTGGCATTACTCCACTTCAAGTAAGAGTTTGG-3’ to 5’-
ACTAATGCCACTACTTTACTCCACTTCAAGTAAGAGTTTGG-3’. This modification 
enables us to use specific primers to detect only the exogenous but not endogenous HMRA1 
in a WT yeast strain. DNA templates for in vitro transcription were generated after the 
addition of three copies of MS2 stem loops to the 5′-end of the ACT1 gene or to the 3’-end 
of the UBC4, DYN2, EFM5, and HMRA1 genes. Pre-mRNA substrates were generated by 
run-off transcription from linearized plasmid DNA templates, and capped using Vaccinia 
Capping System (New England Biolabs) if indicated.
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To obtain the yeast complex E for structural studies, the Act1 or Ubc4 pre-mRNA substrate 
was bound to the MBP-MS2 fusion protein and mixed with purified U1 snRNP 23 and BBP/
Mud2 dimer (or BBP/Mud2-CBP in the case of Act1), then applied to amylose resin (New 
England Biolabs) pre-washed with buffer G120 (20 mM HEPES, pH 7.9, 120 mM KCl, 
0.01% NP-40). After 3 h incubation at 4 °C, the resin was washed and eluted with buffer 
G120 containing 10 mM maltose. Elutions were pooled and applied to 100 μL of calmodulin 
resin (Agilent) pre-washed with washing buffer (20 mM Hepes, pH7.9, 120 mM KCl, 2 mM 
CaCl2, 1 mM imidazole, 0.01% NP-40), and incubated for 3 hr at 4 °C. The resin was 
washed with washing buffer, and eluted 6 times with 100 μL eluting buffer (20 mM Hepes, 
pH7.9, 120 mM KCl, 2 mM EGTA) each time. The elutions containing the most 
concentrated E complex were used for cryoEM imaging. Crosslinked sample was prepared 
by treating the complex with 1 mM BS3 (Thermo Fisher) on ice for 30 min, and 
subsequently quenched with 50 mM Tris (pH8.0).
CryoEM sample preparation and imaging
For cryoEM sample optimization, an aliquot of 3 μl of sample (~0.2-0.5 μM) was applied 
onto a glow-discharged lacey carbon film-coated copper grid (400 mesh, Ted Pella). The 
grid was blotted with Grade 595 filter paper (Ted Pella) and flash-frozen in liquid ethane 
with a FEI Mark IV Vitrobot. A FEI TF20 cryoEM instrument was used to screen grids. 
CryoEM grids with optimal particle distribution and ice thickness were obtained by varying 
the gas source (air using PELCO easiGlow™, target vacuum of 0.37 mbar, target current of 
15 mA; or H2/O2 using Gatan Model 950 advanced plasma system, target vacuum of 70 
mTorr, target power of 50 W) and time for glow discharge, the volume of applied samples, 
chamber temperature and humidity, blotting time and force, as well as wait time before 
blotting. Our best grids for the Act1 complex were obtained with 50 s glow discharge using 
air and with the Vitrobot sample chamber set at 12°C temperature, 100% humidity, 2.5 s 
blotting time, −3 blotting force and 20 s wait time. The best grids for Ubc4 complex were 
obtained with 60 s glow discharge using air and with the Vitrobot sample chamber set at 
12°C temperature, 100% humidity, 3 s blotting time, 1 blotting force and 60 s wait time.
Optimized cryoEM grids were loaded into a FEI Titan Krios electron microscope with a 
Gatan Imaging Filter (GIF) Quantum LS device and a post-GIF K2 Summit direct electron 
detector. The microscope was operated at 300 kV with the GIF energy-filtering slit width set 
at 20 eV. Movies were acquired with Leginon 39 by electron counting in either super-
resolution mode at a pixel size of 0.68 Å/pixel (Act1 complex) or counting mode at a pixel 
size of 1.36 Å/pixel (Ubc4 complex). A total number of 40 frames were acquired in 8 
seconds for each movie, giving a total dose of ~30 e-/Å2/movie.
Drift correction for movie frames
Frames in each movie were aligned for drift correction with the GPU-accelerated program 
MotionCor2 40. The first frame was skipped during drift correction due to concern of more 
severe drift/charging of this frame. Two averaged micrographs, one with dose weighting and 
the other without dose weighting, were generated for each movie after drift correction. The 
averaged micrographs have a calibrated pixel size of 1.36 Å on the specimen scale. The 
averaged micrographs without dose weighting were used only for defocus determination and 
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the averaged micrographs with dose weighting were used for all other steps of image 
processing.
Structure determination for the Act1 complex
For the Act1 complex, the defocus value of each averaged micrograph was determined by 
CTFFIND4 41 to be ranging from −1.5 to −3 μm. Initially, a total of 3,589,121 particles were 
automatically picked from 11,283 averaged micrographs without reference using 
Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang). The particles were boxed out in 
dimensions of 352 × 352 square pixels square and binned to 176 × 176 square pixels (pixel 
size of 2.72 Å) before further processing by the GPU accelerated RELION2.1. The reported 
U1 model (EMD-8622) was low-pass filtered to 60 Å to serve as an initial model for 3D 
classification. After one round of 3D classification, only the classes exhibiting features 
characteristic of the E complex (e.g., 5’ss and pre-mRNA helix binding to U1 snRNP) were 
kept, which contained 1,852,842 particles. Several iterations of reference-free 2D 
classification were subsequently performed to remove “bad” particles (i.e., classes with 
fuzzy or un-interpretable features), yielding 1,108,069 good particles. Auto-refinement of 
these particles by RELION yielded a map with an average resolution of 5.44 Å (“Step 1” in 
Extended Data Fig. 2c).
Next, we performed two rounds of focused classification on the pre-mRNA helix region of 
the E complex to further eliminate those particles without the pre-mRNA helix (“Step2” in 
Extended Data Fig. 2c). The first round of this focused classification generated one good 
class containing 390,792 particles. These particles were un-binned to 352 × 352 square 
pixels (pixel size of 1.36 Å) and subjected to another round of focused classification. We re-
centered the particles from one best class and removed duplications based on the unique 
index of each particle given by RELION.
The 270,587 un-binned, unique particles (7.5% of all particles) resulting from the focused 
classification were subjected to a final step of 3D auto-refinement (“Step 3” in Extended 
Data Fig. 2c). The two half maps from this auto-refinement step were subjected to 
RELION’s standard post-processing procedure. The final map of the Act1 complex has an 
average resolution of 3.2 Å based on RELION’s gold-standard FSC (see below).
Structure determination for the Ubc4 complex
For the Ubc4 complex, the defocus value of each averaged micrograph was determined by 
CTFFIND4 to be ranging from −1.5 to −3 μm. Initially, a total of 1,924,710 particles were 
automatically picked from 8,997 averaged micrographs without reference using Gautomatch. 
The particles were boxed out in dimensions of 384 × 384 square pixels square and binned to 
192 × 192 square pixels (pixel size of 2.72 Å) before further processing by the GPU 
accelerated RELION2.1. The reported U1 model (EMD-8622) was low-pass filtered to 60 Å 
to serve as an initial model for 3D classification. After one round of 3D classification, only 
the classes showing features corresponding to the E complex (e.g., 5’ss binding to U1 
snRNP) were kept, which contained 800,735 particles. Several iterations of reference-free 
2D classification were subsequently performed to remove bad particles (i.e., classes with 
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fuzzy or un-interpretable features), yielding 756,303 good particles (“Step1” in Extended 
Data Fig. 3c).
Next, we performed another two rounds of 3D classification to further improve the ratio of 
the intact E complex (e.g., Prp40, NCBP1/NCBP2, and Nam8 binding) (“Step2” in 
Extended Data Fig. 3c). During each round of the 3D classification, only one class showed 
features corresponding to the intact E complex monomer (Likely due to the cross-linking 
reagent used for the Ubc4 complex, one class from the second round of 3D classification 
exhibiting features characteristic of the E complex dimer). These good particles from the 
final round of 3D classification were un-binned to 384 × 384 square pixels (pixel size of 
1.36 Å). We re-centered these particles and removed duplications based on the unique index 
of each particle given by RELION.
The resulting 124,825 un-binned, unique particles (6.5% of all particles) were subjected to a 
final step of 3D auto-refinement (“Step 3” in Extended Data Fig. 3c). The two half maps 
from this auto-refinement step were subjected to RELION’s standard post-processing 
procedure. The final map of the Ubc4 complex has an average resolution of 3.6 Å based on 
RELION’s gold-standard FSC (see below).
Resolution assessment
All resolutions reported above are based on the “gold-standard” FSC 0.143 criterion 42. FSC 
curves were calculated using soft spherical masks and high-resolution noise substitution was 
used to correct for convolution effects of the masks on the FSC curves 43. Prior to 
visualization, all maps were sharpened by applying a negative B-factor which was estimated 
using automated procedures 44.
Local resolution was estimated using ResMap 45. The overall quality of the maps for Act1 
and Ubc4 complexes is presented in Extended Data Figs. 2b-d and 3b-d, respectively. Data 
collection and reconstruction statistics are presented in Extended Data Table 1.
Model building and refinement
To aid subunit assignment and model building, we took advantage of the reported U1 
structure (PDB code: 5UZ5, 3.7 Å), which were fitted into the Ubc4 complex density map 
by UCSF CHIMERA 46. The central regions of the Ubc4 complex have resolutions ranging 
from 3.0 to 4.5 Å (Extended Data Fig. 3f); thus protein and RNA components in these 
regions were rebuilt manually using COOT 47. Briefly, for protein subunits that match well 
with the densities in the Ubc4 complex structure, we manually adjusted their side chain 
conformation and, when necessary, moved their main chains to match the density map. For 
protein subunits that exhibit significant main chain mismatches or have not been identified, 
we built atomic models de novo. To do so, sequence assignment was mainly guided by 
visible densities of amino acid residues with bulky side chains, such as Trp, Tyr, Phe, and 
Arg. Other residues including Gly and Pro also helped the assignment process. Unique 
patterns of sequence segments containing such residues were utilized for validation of 
residue assignment.
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For the RNA region near 5’ss (nt −2 to +8 of pre-mRNA with respect to the exon-intron 
junction; nt 1-10 of the U1 snRNA), the well-defined nucleotide densities, along with the 
base pairs between U1 snRNA and pre-mRNA, facilitated the RNA model building process. 
RNA model building in these regions was performed de novo in COOT. For the central 
regions of U1 snRNA, the previous U1 snRNA model was adjusted for their base 
conformation and, when necessary, for their main chains to match the density map. The 
RNA components were subsequently adjusted using RCrane 48 and ERRASER 49.
Models built for the protein and RNA subunits in these central regions include: U1-70K (aa 
1-91), U1C (aa 3-197), U1A (aa 2-46, 55-125, 133-148), Prp42 (aa 1-544), Prp39 (aa 
288-553, 561-627), Nam8 (aa 291-425, 432-449, 492-523), Snu56 (aa 43-170, 185-295), 
Snu71 (aa 1-52), Luc7 (aa 4-19, 38-140, 172-244), Sm ring; the core regions of U1 snRNA 
(Extended Data Fig. 4), pre-mRNA (nt −2 to +8 with respect to the exon-intron junction). 
The long helix interacting with ZnF2 and the coiled coil domain of Luc7 was traced with 
poly-alanine, which likely belongs to Snu71 since deletion of the coiled coil domain of Luc7 
reduces its interaction with Snu71 and Prp40 but only Snu71 has isolated long helices 
(Extended Data Fig. 7B).
Resolutions for the periphery of the Ubc4 complex were more varied, ranging from 6 Å to 
25 Å, insufficient for de novo atomic modeling. The following proteins were built with 
homology modeling using I-TASSER server and rigidly docked into the low-pass filtered 
map of the 3.6 Å map using CHIMERA: RRM domain of U1-70K (aa 94-188), N-terminal 
region of Prp39 (aa 43-285), and RRM2 domain of Nam8 (aa 161-242). The homology 
model of NCBP1/NCBP2 heterodimer (NCBP1:616 aa 36-861; NCBP2: aa 19-156) was 
rigidly fitted into its local refinement map. In addition, the periphery region has a 
boomerang-shaped density which matches well with that of the crystal structures of tandem 
FF domains connected by long helices 21,22. We assigned this density as the Prp40 FF4-6 
domains, considering that DSSO crosslinking in the Ubc4 complex and mass spectrometry 
analyses demonstrate that the C-terminal FF domains crosslink to U1-70K (Extended Data 
Fig. 7A) and that there is weak density connecting the boomerang-shaped density and 
U1-70K, although we cannot rule out the possibility of this density being the other tandem 
FF domains such as FF3-5. The FF4 (aa 355-413, from I-TASSER), FF5 (aa 427-488, from 
I-TASSER) and FF6 (aa 491-552, PDB: 2KFD) domains were rigidly docked into the low-
pass filtered map using CHIMERA, and manually connected using COOT with the long 
helix between FF domains (Fig. 2F).
Except for nucleotides 27-33 at the tip of Stem-Loop 1 and the last three nucleotides 
566-568, the entire U1 snRNA is now modeled with DRRAFTER 50. The estimated mean 
RMSD accuracies for the DRRAFTER models are: The estimated mean RMSD accuracies 
for the DRRAFTER models are: 0.4 Å for residues 39-41, 4.3 Å for residues 97-103, 0.7 Å 
for residues 175-177, 3.5 Å for residues 202-236, 3.0 Å for residues 289-294, and 4.9 Å for 
residues 325-516. The median structures of the best ten scoring models are shown in Fig. 
2A. Using the low-pass filtered map, we could also manually trace the main chain for nt −9 
to −3 and nt +9 to +13 of pre-mRNA. Combined with the previous atomic model, 23 
nucleotides of the pre-mRNA were manually built, of which the upstream could directly 
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insert into NCBP1/NCBP2 heterodimer and the downstream could interact with the RRM2 
domain of Nam8.
The model of the pre-RNA helix and the putative localization of the BBP/Mud2 binding 
region were based on the 3.2Å resolution structure of the Act1 complex. The modeling 
procedure is similar to that used for modeling the Ubc4 complex except for the following 
differences. Firstly, we could observe the density for ~25bp double RNA helix with clear 
major and minor grooves on a binding surface formed by the C-terminal tail of Prp39, the N-
terminal domain of Prp42, and the C-terminal domain of U1C. Such double helix density 
was also observed in the pre-B complex structure and was tentatively modeled as part of U2 
snRNA. Since our Act1 complex was assembled from in vitro transcribed Act1 pre-mRNA, 
purified U1 snRNP, BBP, and Mud2 proteins, there is no U2 snRNA present in our sample 
(Extended Data Fig. 5B). Although some bases can be separated in the density map of this 
double helix, we were unable to model specific nucleotides. Nonetheless, there is weak 
density connecting it to the 5’ ss, suggesting that this double helix belongs to the pre-mRNA 
region downstream of the 5’ ss. Secondly, there is a large volume of weak density close to 
pre-mRNA double helix (Extended Data Fig. 4I). The density can be best interpreted as the 
BBP/Mud2 dimer bound to pre-mRNA, given that its location corresponds roughly to where 
U2 SnRNP is in the A complex structure (Extended Data Fig. 4I).
The above models were refined using PHENIX in real space 51 with secondary structure and 
geometry restraints. Refinement statistics of the E complex were summarized in Extended 
Data Table 1. These models were also evaluated based on Morprobity scores 52 and 
Ramachandran plots (Extended Data Table 1). Model/map FSC validation was shown in 
Extended Data Fig. 2g and 3g. Representative densities for the proteins and RNA are shown 
in Extended Data Fig. 4. All structure-related images in this paper were generated using 
UCSF CHIMERA 46 and CHIMERAX 53.
To determine the minimum number of nucleotides needed to connect an upstream BPS to a 
downstream 5’ SS in the A complex14, we modeled connection lengths ranging from 21 to 
30 nucleotides between nucleotides 74 and −1 of pre-mRNA (chain I in PDB ID 6g90, 
nucleotide 70 is BP and +1 is 5’ ss) using the Rosetta RNP-denovo method with full-atom 
refinement 28,50. Nucleotides 75-78 of pre-mRNA were excised from the structure and all 
other nucleotides were kept fixed. 21-30 uridines were modeled de novo to connect 
nucleotide 74 to nucleotide −1. During the initial low-resolution stages of the modeling, 
score terms rewarding favorable RNA-protein interactions, RNA base pairing, and compact 
RNA structures were turned off. Score terms that penalize clashes within the RNA and 
between the RNA and protein were included during this stage. During the final all-atom 
refinement, the complete all-atom RNA-protein score function was used. The weight on the 
score term penalizing chainbreaks was increased to 50.0 and models with a chainbreak score 
less than 0.5 were considered fully connected. The top scoring model (at least 250 models 
were built for each connection length) by full Rosetta score was used as a representative 
model for each connection length. We found that the representative model for 22-nucleotide 
connection length is fully connected and has similar total Rosetta score as models for longer 
connection lengths, indicating 22 nucleotides are sufficient for connecting nucleotide 74 to 
−1 without highly unfavorable interactions such as clashes.
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Crosslinking and mass spectrometry
Purified yeast spliceosome E complex was crosslinked with 10 mM DSSO (disuccinimidyl 
sulfoxide) for 45 min at 4 °C, the reaction was quenched by adding ammonium bicarbonate 
to a final concentration of 50 mM. Crosslinked complex was proteolytically digested 
according to the FASP (filter-aided sample preparation) protocol as previously described 54. 
Briefly, ~100 μg of crosslinked sample was reduced, alkylated, and digested at 1:50 with 
sequencing grade trypsin (Promega) by incubating at 37 °C for 18 hours. Peptides were 
eluted and acidified to 0.1 % formic acid. Enrichment of crosslinked peptides was performed 
by using strong cation exchange chromatography (SCX) with a Dionex UltiMate 3000 
system (Thermo Fisher Scientific). A Proteomix SCX-NP1.7 column (4.6 mm inner 
diameter, 150 mm length, Sepax Technologies) was used. Briefly, peptides were separated 
using the following gradient: 0 % B (0 – 3.5 min), 0 – 22.5 % B (3.5 – 18.5 min), 22.5 – 
50 % B (18.5 – 21.5 min), 50 – 100 % B (21.5 – 23 min), 100 % B (23 – 25.5 min) with 
solvent A (10 mM KH2PO4, 25 % acetonitrile, pH 3.00) and solvent B (10 mM KH2PO4, 
25 % acetonitrile, 500 mM KCl, pH 3.00) at a flow rate of 0.7 ml/min. Fractions were 
collected every minute. Fractions 6-26 were pooled into groups of three and desalted using 
StageTips for subsequent LC-MS/MS analysis.
Crosslinked peptides were then analyzed by nano-UHPLC-MS/MS (Easy-nLC1200, 
Orbitrap Fusion™ Lumos™Tribrid™, Thermo Fisher Scientific). 14 μl of sample was 
directly loaded onto an in-house packed 100 μm i.d. × 250 mm fused silica column packed 
with CORTECS C18 resin (2.7 μm, spherical solid-core). Samples were run at 400 nL/min 
over a 90 min linear gradient from 4-32% acetonitrile with 0.1% formic acid. The mass 
spectrometer was operated in positive ion mode with two sequential experiments per duty 
cycle. For crosslink peptide identification, MS1 scans were ran in the orbitrap from 
375-1500 m/z at 60,000 resolution. MS2 was performed on the top 4 ions from each 
precursor scan and fragmented at a CID collision energy of 22%. MS3 was triggered by the 
targeted mass difference of 31.9721 Da represented by the cleavage of the DSSO sulfoxide 
bond, and was performed as a stepped HCD collision energy of 33% +/−3. For linear peptide 
identification, a second precursor scan was performed at 120000 resolution in a scan range 
of 350-1000 m/z. Stoichiometric sampling of ions for MS2 fragmentation was capped at 2 
seconds and performed at an HCD collision energy of 30% in the orbitrap. Data acquisition 
was performed using Xcalibur (version 4.1) software.
Instrument raw files were directly loaded in to Proteome Discoverer 2.2 and were searched 
against twenty-two proteins making up the E Complex of U1snRNP from S. cerevisiae of 
the Swiss-prot database (update 2018_08_08) using the XlinkX plugin. Search parameters 
included carbamidomethylation-C as a fixed modification, oxidation-M, DSSO-K, DSSO/
amidated-K, and DSSO/hydrolysed-K as variable modifications, allowing for two missed 
cleavages. MS2_MS3 was set for crosslink detection against DSSO. Precursor mass 
tolerance was set to 10 ppm, with MS/MS mass tolerance set to 20 ppm. Results were 
manually validated and visualized using xVis 55.
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Oligo-directed RNase H digestion of pre-mRNA in purified E complex
Purified E complex with Act1 or Dyn2 IEI pre-mRNA as substrate was incubated with 
RNase H (New England Biolabs) in the presence or absence of 5 μM DNA oligo, at 25 °C 
for 30 min. The complex was then bound to amylose resin pre-washed with buffer G120. 
The resin was washed with buffer G120 and eluted in buffer G120 containing 10 mM 
maltose. The eluted samples were analyzed on SDS-PAGE and stained with Coomassie to 
visualize the proteins. For RNA detection, the samples were digested with 1 μg/μL 
proteinase K and separated on 7M urea denaturing polyacrylamide gel and stained with 
EtBr, or on native agarose gel and stained with SYBR gold (Life Technologies). DNA oligo 
used for digestion of Act1 is 5’-AAAATAAACGATGACACAG-3’, and for Dyn2 is 5’-
TCATGGAAGAAAACCTCAC-3’.
Chase experiment with assembled E complex in U1-depleted yeast extract
BSY82 (GAL-U1) yeast strain 56 obtained from Dr. Michael Rosbash’s lab was maintained 
in YEP media containing 2% galactose. For U1 snRNA depletion cultures, log phase cells 
growing in 2% galactose were diluted into 2% glucose containing media to an OD600 of 
0.03 and grown for 17 h to an OD600 of 2.5. Yeast splicing extracts were prepared from 2 
liters of yeast cells cultured in media containing either galactose or glucose. Splicing 
reactions were carried out at 23°C for 15 min in a 25 μL reaction containing 2.5 nM M3-
Act1 pre-mRNA alone or purified E complex, with or without 50-fold (in molar quantity) of 
Act1-M3 (Act1 pre-mRNA containing 54nt 3’ exon fused with three copies of MS2 stem 
loops at the 3′-end), 40% yeast extract, and splicing buffer (60 mM potassium phosphate, 
pH 7.4, 3% PEG 8000, 2.5 mM MgCl2, 2 mM ATP). RNAs were then phenol/chloroform 
extracted and precipitated with 2.5 volumes of ethanol. After DNase I (Roche) treatment, 
first strand cDNAs were synthesized from 1 μg of RNA using ProtoScript II reverse 
transcriptase with reverse primers specific to M3-Act1, U1 snRNA, or U2 snRNA. PCR was 
performed using cDNA transcribed from 25 ng of RNA as template and the following 
primers: MS2 Forward 5’-TCCGATATCCGTACACCATC-3’; Act1 exon 2 Reverse 5’-
TGATACCTTGGTGTCTTGGTCT-3’; yeast U1 Forward 5’-
AAACATGCGCTTCCAATAGT-3’, Reverse 5’-
TATGTGTGTGTGACCAAGGAG-3’57(75); and yeast U2 Forward 5’-
AACTGAAATGACCTCAATGAGGCTC-3’, Reverse 5’- 
AGACCTGACATTAGCGGAAAACAAC-3’. The products were analyzed on 3% low 
melting point (LMP) agarose gel stained with EtBr.
The same experiment was also performed using EFM5 IEI-101-M3 or HMRA1 IEI-246-M3 
pre-mRNA and E complex assembled on both pre-mRNAs. A second EFM5 IEI-101 pre-
mRNA was designed to remove the primer binding sites so it is invisible in the RT-PCR 
reaction and was in vitro transcribed to be used as competing RNA. For HMRA1, wild type 
IEI-246 pre-mRNA was used as competing RNA. Primers used to detect circRNA formed 
specifically from EFM5 IEI-101 are: IEI-101 cir Forward 5’- 
CCTTGAAGAATTCAAAAGAGAGGATAG −3’ and cir Reverse 5’- 
CGAGGGCATTAGCAGAAAG −3’. Primers used to detect circRNA formed specifically 
from HMRA1 IEI-246 are: IEI-62 cir Forward 5’-TCCACTTCAAGTAAGAGTTTGG-3’ 
and cir Reverse 5’- GAGTAAAGTAGTGGCATTAGTCA-3’.
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Analyzing the role of Act1 intronic secondary structure in splicing
We mutated multiple stretches of sequences in the 5’ ss to BPS region of Act1 so that it no 
longer forms extensive secondary structures. The final sequence of this region (mutated 
nucleotides underlined) is: 
GTATGTTCTAGCGCTTGCACCATCCCATTTAACTGTAAAAAAAAATGCACGGTCCC
AATTGCTCGAGAGATTTCTCTTTTACAAAAAAATACTATTAAAAAAAGAGAAAAA
ACCTCCTATATTGACTGATCTGTAATAACCACGATATTATTGGAATAAATAGGGGCT
AAAAATTTGGAAAAAAAGAAAAACTGAAATATTTTCGTGATAAGTGATAGTGATA
AAAAAAAATTATTTGCTACTGTGTCTCATGTACTAA. We synthesized this mutant 
region through Genscript and replaced the 5’ ss to BPS region of the Act1-Cup1 reporter 
plasmid 19 with this sequence to generate the mutant reporter plasmid pMA6.
The WT and mutant Act1-Cup1 reporter plasmids were transformed into yeast strain 
BY4741, and grown in synthetic complete (SC) -Leu medium until OD600=1.0. RNA is 
extracted from 5 mls of culture, treated with DNase I (Roche), and reverse transcribed using 
the ProtoScript II First Strand cDNA Synthesis Kit (New England Biolabs) and random 
primers. qPCR was performed using the iTaq™ Universal SYBR® Green Supermix 
(Biorad) with cDNA transcribed from 10 ng of RNA as template. The primers for detecting 
pre-mRNAs are located in the Act1 intron and Cup1: Act intron Forward 5’-
TTATTTGCTACTGTGTCTCATG-3’; YAC7 Reverse 5’- 
GCATTGGCACTCATGACCTT-3’. The primers for detecting total reporter mRNA are 
located in Act1 exon 2 and Cup1: ActEx2 Forward 5’- GTTCTGGTATGTGTAAAGCC-3’; 
CUP1end Reverse 5’-CCAGAGCAGCATGATTTCTT-3’.
Co-purification assay in yeast
The coding regions of yeast Prp40, Snu71, and Luc7 full length or truncations were 
amplified by PCR using genomic S. cerevisiae DNA as templates, and ligated into pRS414, 
pRS416 and pRS317 vectors. The final plasmids constructed are: pRS414/GPD-protA-Prp40 
(full-length, FF1-3 and FF4-6), pRS317/GPD-Prp40, pRS414/GPD-protA-Snu71, pRS416/
GPD-CBP-Luc7 or Luc7ΔCC (Luc7 coiled coil domain (residues 123-190) deletion). Yeast 
BCY123 cells were transformed with different combination of the plasmids and selected on 
appropriate selective media. Clones from the transformation were cultured in 50 ml of liquid 
selective media to OD600=3-4. Cells were harvested and lysed in lysis buffer (50 mM Tris-
HCl, pH 8.0, 150 mM NaCl, 0.05% NP40, 1 mM DTT, 2.5mM CaCl2, 1.5mM MgCl2) using 
the bead-beating method. The lysates were incubated with IgG resin for 3 hr at 4°C. The 
resins were washed with the lysis buffer. The proteins were cleaved off IgG resin using TEV 
protease in buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.01% NP40, 0.5mM DTT). 
The proteins were separated on SDS-PAGE and transferred to a nitrocellulose membrane. 
Western blot was performed using an anti-CBP tag antibody (GenScript, A00635).
Dyn2 splicing analyses
The DYN2 gene was PCR amplified from S. cerevisiae genomic DNA along with the 5′-
UTR (356 bp) and 3′-UTR (305 bp) and cloned into the pRS415 vector. The BPS of the first 
intron was mutated from “TACTAAC” to “TAGTACC” and the 5’SS of the second intron 
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from “GT” to “CG” separately or together, to generate the I1-BP, I2-5’SS, and double 
mutant. The wild type and mutant plasmids were transformed into a DYN2 deletion yeast 
strain (Open Biosystem), and transformants were selected on SC -Leu plates. Cells were 
grown in SC -Leu media to OD600 of ~1.0. Total RNA was isolated from 10 ml of cells 
using a hot-phenol extraction method and dissolved in 100 μl of diethylpyrocarbonate 
(DEPC)-treated water. A total of 1 μg of RNA was treated with DNase I and reverse 
transcribed into cDNA. qPCRs were performed using the following primers: E1 Forward 5’-
CCAAAATGAGCGATGAAAATAAGAG-3’ and I1 Reverse 5’-
TCATGGAAGAAAACCTCACTC-3’ to detect exon 1-intron 1 product; I1 Forward 5’-
TATGTCAGTTAATCTCAGTCACAAT-3’ and E2 Reverse 5’-
TATGTCAGACGCCTTAACAATAG-3’ to detect intron 1-exon 2 product; E2 Forward 5’-
CTATTGTTAAGGCGTCTGACATA-3’ and I2 Reverse 5’-
GGTCTAAGTTTTCTCCTTGTTAG −3’ to detect exon 2-intron 2 product; I2 Forward 5’-
CATGTTTTGTGTGTGTACATTTG-3’ and E3 Reverse 5’-
CAGGTATTGCCGTATTTGAC-3’ to detect intron 2-exon 3 product; E3 Forward 5’-
CGACAAGCTGAAAGAGGATA-3’ and E3 reverse to detect exon 3.
CircRNA detection from purified spliceosome
Spliceosome was purified from three liters of yeast cells carrying the Prp22H060A mutant to 
enrich the post-catalytical complex 20 to increase our chance of detecting branching and 
ligation products before their release. RNA from the purified spliceosomal complex was 
purified and reverse transcribed into cDNA. PCR was performed to detect the presence of T-
branches and circRNAs from yeast multi-intronic genes EFM5 (YGR001C) and HMRA1 
(YCR097W), using circle-specific primers 7 and the following primers for T-branches: 
EFM5 I1 Forward 5’- TTTTCAACACAGTAACGTAGAATTAC-3’, I2 Reverse 5’- 
AACAGTTAGTAAGATGAAAAGATACTGG-3’; HMRA1 I1 Forward 5’-
GTATGTTTTCATTTCAAGGATAG-3’, I2 Reverse 5’-
TGTTAGTATAGGATATATTTAAGTTTGA-3’. PCR products were analyzed on 3.5% LMP 
agarose gel stained with EtBr, and cloned into pMiniT vectors (New England Biolabs) for 
sequencing.
CircRNA detection from EFM5 and HMRA1 IEI constructs in vivo
The region from +47 to +630 of EFM5 gene (containing EFM5 partial intron 1, exon 2, and 
partial intron 2) was PCR amplified from S. cerevisiae genomic DNA and was inserted 
between a GPD promoter and a CYC1 terminator, and the resulting expression cassette was 
cloned into a pRS317 vector, generating the EFM5 IEI plasmid. The BPS of the first intron 
was mutated from “TACTAACTAAC” to “TAGTACCTACC” (mutations underlined) 58 and 
the 5’SS of the second intron from “GT” to “CG” separately, to generate the BP and 5’SS 
mutant. The IEI-101 truncation was generated by fusing the first 49 nt to the last 52 nt of the 
middle exon. The IEI-63 truncation was engineered on IEI-101 to shorten the middle exon to 
63 nt in length, of which the sequence is: 5’-
GACACTTTCTGCCCTTGAAGAATTCAAAAGAGAGGATAGATTGTTAATTGACCCA
AACAAAGT-3’.
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The EFM5 IEI plasmid and the empty pRS317 vector were transformed into an EFM5 
deletion yeast strain (Open Biosystem). Cells were grown in SC -Lys media to OD 600 of 
~1.0. Total RNA was isolated and reverse transcribed into cDNA. For RNase R treatment, 1 
μg of total RNA was incubated at 37 °C for 30 min with 5 U/ μg of RNase R (Epicentre 
Technologies) and used directly for reverse transcription without further purification. PCR 
was performed using specific primers 7 to detect circRNA formed from exon2 of EFM5 
using the following primers: EFM5 cir Forward 5’-
GAGAGGATAGATTGTTAATTGACCC-3’ and EFM5 cir Reverse 5’- 
CTTTTGAATTCTTCAAGGGCA-3’. The primer pair used to detect un-spliced EFM5 pre-
mRNA are: EFM5 I1 Forward 5’-TTTTCAACACAGTAACGT AGAATTAC-3’, I2 Reverse 
5’- GAGTAGGGATATGTTTATGATATACATAC −3’. The products were analyzed on 3% 
LMP agarose gel stained with EtBr.
The region from +116 to +439 of HMRA1 gene (containing exon 2 flanked by partial intron 
1 and intron 2) was PCR amplified from S. cerevisiae genomic DNA and cloned into 
pRS317 vector in the same way. The IEI-62 truncation was engineered to shorten the middle 
exon to 62 nt in length, of which the sequence is: 5’-TTTATAATGGAAAGTAATTTGAC 
TAATGCCACTACTTTACTCCACTTCAAGTAAGAGTTTGG −3’. Primers used to detect 
circRNA are IEI-62 cir Forward and Reverse primer, which are the same as those used for 
IEI-246. The primer pair used to detect un-spliced HMRA1 pre-mRNA are: HMRA1 I1 
Forward 5’-CCA 
AGAACTTAGTTTCGACTCTAGATTTCAAGGATAGCCTTTGAATC-3’, I2 Reverse 5’- 
AACTAATTACATGATGGGCCCGGATATATTTAAGTTTGATTCTCATATTACATAC-3’.
Extended Data
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Extended Data Figure 1. In vitro assembly and purification of the Act1 complex.
(a) A schematic representation of the Act1 pre-mRNA tagged with three MS2-binding sites 
(M3-Act1) used for E complex assembly and purification. Boxes represent exon 1 (E1) and 
truncated exon 2 (E2). The 5’ ss (GU) and BPS (UACUAAC) are also shown. The red line 
represents the DNA oligo complementary to a region 5nt upstream of the BPS for the RNase 
H cleavage experiment. (b) RNA components of the assembled E complex (with or without 
DNA oligo and RNase H treatment) after proteinase K digestion are shown on a denaturing 
urea gel or native agarose gel. These results demonstrate that RNase treatment cleaved M3-
Act1 into two fragments. Note that the sizes of RNA on the native gel do not match their 
linear length, possibly due to the existence of secondary structures. This experiment was 
repeated two additional times with similar results.
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Extended Data Figure 2. The CryoEM structural determination process for the Act1 complex.
(a) A representative drift-corrected cryoEM micrograph (out of a total of 11,283 images) of 
the E complex assembled on the Act1 pre-mRNA. A representative particle is shown in a 
white dotted circle. (b) Representative 2D class averages of the Act1 complex obtained in 
RELION. This experiment was repeated one additional time with similar results. (c) Data 
processing workflow. For processing above the red dash line, the particle images were 
binned to a pixel size of 2.72 Å. The rest of processing was performed with a pixel size of 
1.36 Å. The masks used in data processing are outlined with red solid line. Please refer to 
Methods for more details. (d) Angular distribution for all particles used for the final 3.2 Å 
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map of the Act1 complex. (e) FSC as a function of spatial frequency demonstrating the 
resolution for the final reconstruction of the Act1 complex. (f) Resmap local resolution 
estimation. (g) FSC coefficients as a functional of spatial frequency between model and 
cryoEM density maps. The generally similar appearances between the FSC curves obtained 
with half maps with (red) and without (blue) model refinement indicate that the refinement 
of the atomic coordinates did not suffer from severe over-fitting.
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Extended Data Figure 3. The CryoEM structural determination process for the Ubc4 complex.
(a) A representative drift-corrected cryoEM micrograph (out of a total of 8,997 micrographs) 
of the E complex assembled on the Ubc4 pre-mRNA. A representative particle is shown in a 
white dotted circle. (b) Representative 2D class averages of the Ubc4 complex obtained in 
RELION. (e) 2D classification of negative-stain TEM images of the E complex assembled 
on Dyn2 IEI pre-mRNA. This experiment was repeated one additional time with similar 
results. (c) Data processing workflow. For processing above the red dash line, the particle 
images were binned to a pixel size of 2.72 Å. The rest of processing was performed with a 
pixel size of 1.36 Å. The masks used in data processing are outlined with red solid line. 
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Please refer to Methods for more details. (d) Angular distribution for all particles used for 
the final 3.6 Å map of the Ubc4 complex. (e) FSC as a function of spatial frequency 
demonstrating the resolution for the final reconstruction of the Ubc4 complex. (f) Resmap 
local resolution estimation. (g) FSC coefficients as a functional of spatial frequency between 
model and cryoEM density maps. The generally similar appearances between the FSC 
curves obtained with half maps with (red) and without (blue) model refinement indicate that 
the refinement of the atomic coordinates did not suffer from severe over-fitting.
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Extended Data Figure 4. Representative cryoEM density maps of the E complex.
Panels (a-i) are densities for the Ubc4 complex and (j) is density for the Act1 complex. The 
cryoEM density maps are shown for (a) selected regions of U1 snRNA; (b) C-terminal 
region of Prp39; (c) N-terminal domain of Snu71; (d) the pre-mRNA and U1 snRNA 
duplex; (e) U1C ZnF domain; (f) Luc7 ZnF2 domain; (g) the tandem FF domains of Prp40 
(known structures of tandem FF domains from CA150 are also shown with the characteristic 
boomerang-shape); (h) the RRM2 domain of Nam8; (i) NCBP1 and NCBP2; (j) the weak 
density in the Act1 complex that is assigned as the putative BBP/Mud2 heterodimer. The A 
complex is also shown, with U1 snRNP in the same orientation as the Act1 complex and U2 
snRNP located in similar positions as the BBP/Mud2 heterodimer with respect to U1 snRNP. 
The map of Act1 complex was low-pass filtered to 40 Å.
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Extended Data Figure 5. Structural and biochemical characterization of the Act1 and Ubc4 
complexes.
(a) Comparison of the ribbon models of the Act1 complex, the Ubc4 complexes, and U1 
snRNP from other previously determined structures (the U1 snRNP, A, and pre-B complex). 
Labels in shade indicate protein or RNA components that are different between the Act1 and 
Ubc4 complexes. These components and the RRM2 domain of Nam8 are also absent from 
previously determined structures. Note that U1-70K is shifted towards NCBP2 in the Ubc4 
complex. (b) Purified E complex does not contain U2 snRNA. A native polyacrylamide gel 
shows the solution hybridization (78) result of total cellular RNA or RNA from purified E 
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complex hybridized with fluorescent probes specific for U1 and U2 snRNAs. This 
experiment was repeated one additional time with similar results.
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Extended Data Figure 6. Secondary structures in the region between the 5’ ss and BPS in the 
WT and mutant Act1 and Ubc4 pre-mRNAs.
(a) Secondary structures predicted by RNAstructure 6.0 (https://rna.urmc.rochester.edu/
RNAstructureWeb/). (b) Sequence between the 5’ ss and BPS (underlined) of Act1. Red 
nucleotides were mutated to A (other than the one A which was mutated to G) in the mutant 
Act1 to disrupt predicted secondary structures.
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Extended Data Figure 7. Protein interactions in the Ubc4 complex.
(a) DSSO crosslinking and mass spectrometry analyses of the Ubc4 complex. Each blue line 
indicate crosslinks observed between a pair of Lys residues. Note that BBP/Mud2 are 
crosslinked to Luc7, Prp40, Snu56, and Snu71. (b) Co-purification assays probing the 
interaction between Snu71 (or Prp40) and Luc7. Various combinations of protein A-TEV-
Prp40, protein A-TEV-Snu71, and CBP-tagged Luc7 or Luc7ΔCC [coiled coil domain 
(residues 123-190) of Luc7 deleted] were co-overexpressed in yeast (only Snu71 is protein 
A tagged in the Snu71+Prp40 lanes), purified using IgG resin, eluted through TEV cleavage, 
analyzed on SDS-PAGE, and visualized using both Western blot with an anti-CBP antibody 
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to detect Luc7 (top) and Ponceau S stain to show Snu71 or Prp40 (middle). Western blot 
using the same anti-CBP antibody was used to demonstrate Luc7 expression levels in cell 
lysates (bottom). The faint band around 26 kD in all lanes is TEV. This experiment was 
repeated one additional time with similar results. (c) The linker (residues 73-131) between 
the WW and FF domains of Prp40 is predicted to be disordered using program 
MetaDisorderMD2 (79).
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Extended Data Figure 8. Computational and biochemical characterization of the EDC.
(a) The minimal length of RNA needed to connect the upstream BP and downstream 5’ ss in 
the A complex is modeled using the Rosetta RNP-denovo method. The A complex (PDB ID 
6g90) is shown in grey. The pre-mRNA is shown in green. The upstream BP and 
downstream 5’ ss are shown in purple space filling models. 28 nucleotides are sufficient to 
connect the upstream BP and downstream 5’ ss (not including the BP and 5’ ss themselves) 
without any chainbreak and clashes. (b) Schematics of the Dyn2 pre-mRNA WT and 
mutants (mutated nucleotides shown in red), IEI, and untagged IEI used for the EDC 
assembly and in vivo exon definition experiments. Stem-loops represent the MS2 binding 
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sites, and the red line represents the DNA oligo used for RNase H cleavage. (c) SDS-PAGE 
shows protein components of complexes assembled on WT and IEI substrates (lanes 1-2), on 
WT in the presence of competing untagged IEI (lane 3), and on IEI after RNase H treatment 
in the absence and presence of the DNA oligo (lanes 4-5). This experiment was repeated one 
additional time with similar results. (d) RNA components of the same complexes as in lanes 
4-5 of (b), confirming that RNase H treatment + oligo indeed cleaves the pre-mRNA. The 
smaller cleaved fragment (61 nucleotides) is difficult to see since EtBr has a low efficiency 
staining short single stranded RNA. This experiment was repeated two additional times with 
similar results. (e) Mass spectrometry analyses of spliceosome assembled on the Dyn2 IEI 
and WT pre-mRNA indicate that the two complexes have the same components in similar 
quantities with the exception of NCBP1 and 2 which are absent from the IEI complex. (f) 
2D classification of negative-stain TEM images of the E complex assembled on Dyn2 IEI 
pre-mRNA. This experiment was repeated one additional time with similar results.
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Extended Data Figure 9. Characterization of circRNAs.
(a) Sanger sequencing confirmed that the PCR products in Figure 5A were derived from T-
branches and circRNAs of EFM5 and HMRA1. “/” shows where two ends of exon 2 are 
ligated. “∣” shows where the 5’ ss of intron 2 is ligated to the BP of intron 1. The 5’ ss and 
BPS are shown in bold. The BPS contains deletions (show as -) due to errors caused by 
reverse transcriptase reading through the branch. (b) RT-PCR was carried out on RNA 
extracted from WT yeast cells with or without RNaseR treatment using primers indicated in 
the schematic diagrams below the gel, indicating that RNase R treatment eliminates linear 
RNAs. This experiment was repeated four additional times with similar results. (c) Protein 
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and RNA components of E complex assembled on EFM5 IEI-101-M3 pre-mRNA. (d) RT-
PCR of RNA extracted from BY4742 yeast strain carrying indicated HRMA1 plasmids, with 
or without RNaseR treatment, using primers shown in the schematic diagrams below the gel. 
Numbers 246 and 62 designate exon lengths. Lanes 1-3 indicate all constructs were 
transcribed (endogenous HMRA1 pre-mRNA level is too low to be detected as indicated in 
lane 3). The HMRA1 middle exon was slightly modified to create a circRNA primer binding 
site so that only the modified exogenous (e.g., IEI-246 in lane 5) but not WT HMRA1 
circRNA (IEI-246 WT in lane 4) can be detected. (e) IEI-246-M3 (3xMS2 at the 3’ end) 
RNA or E complex assembled on IEI-246-M3 was incubated with WT or U1-depleted yeast 
extract in the absence or presence of 30-fold excess competing IEI-246 WT RNA. CircRNA 
products were monitored using RT-PCR the same way as (d). Experiments in (c) - (e) were 
repeated one additional time with similar results.
Extended Data Table 1.
Cryo-EM data collection, refinement and validation statistics.
Ubc4 complex
(EMD-0360)
(PDB 6N7P)
Act1 complex
(EMD-0361)
(PDB 6N7R)
Data collection and processing
Magnification 105,000 105,000
Voltage (kV) 300 300
Electron exposure (e−/Å2) 34.6 29.4
Defocus range (μm) −1.5 ~ −3.0 −1.5 ~ −3.0
Pixel size (Å) 1.36 1.36
Symmetry imposed C1 C1
Initial particle images (no.) 1,924,710 3,589,121
Final particle images (no.) 124,825 270,587
Map resolution (Å) 3.6 3.2
 FSC threshold 0.143 0.143
Map resolution range (Å)
 Core 3.0-4.5 3.0-4.5
 Pre-mRNA helix --- 3.0-6.5
 Prp40 15-20 ---
 Nam8 15-20 ---
 NCBPs 15-25 ---
 U1 snRNA 6-15 6-15
Refinement
Initial model used (PDB code) n/a n/a
Model resolution (Å) 4.6 4.3
 FSC threshold 0.5 0.5
Model resolution range (Å) 4.6 4.3
Map sharpening B factor (Å2) −147.1 −94.0
Model composition
 Non-hydrogen atoms 41487 35784
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Ubc4 complex
(EMD-0360)
(PDB 6N7P)
Act1 complex
(EMD-0361)
(PDB 6N7R)
 Protein residues 4839 3568
 Ligands 3 1
B factors (Å2)
 Protein 57.5 59.9
 Ligand 85.3 79.6
R.m.s. deviations
 Bond lengths (Å) 0.01 0.02
 Bond angles (°) 1.35 1.50
Validation
 MolProbity score 1.89 1.99
 Clashscore 5.09 5.07
 Poor rotamers (%) 1.50 2.72
Ramachandran plot
 Favored (%) 92.05 94.21
 Allowed (%) 7.35 5.37
 Disallowed (%) 0.60 0.42
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgements
This work was supported by NIH grants GM126157 and GM130673 (R.Z.); GM071940 and AI094386 (Z.H.Z.); 
and GM122579, GM121487, and CA219847 (R.D.). S.E. is a Howard Hughes Medical Institute Gilliam Fellow. 
K.K. was supported by an NSF GRFP award and a Stanford Graduate Fellowship. We acknowledge the use of 
instruments at the Electron Imaging Center for Nanomachines (supported by UCLA and by grants from the NIH 
(1S10OD018111, 1U24GM116792) and NSF (DBI-1338135 and DMR-1548924)) as well as the CU Anschutz 
School of Medicine Cryo-EM and proteomics core facilities (partially supported by the School of Medicine and the 
University of Colorado Cancer Center Support Grant P30CA046934). Molecular graphics and analyses were 
performed with the UCSF Chimera and ChimeraX, developed by the Resource for Biocomputing, Visualization, 
and Informatics at the University of California, San Francisco, with support from NIGMS P41-GM103311 
(Chimera, ChimeraX) and NIH R01-GM129325 (ChimeraX). We also thank M. Ares, D. Black, and D. Brow for 
comments on early versions of the manuscript.
References
1. Zhang L, Vielle A, Espinosa S & Zhao R RNAs in the spliceosome: Insight from cryoEM structures. 
Wiley interdisciplinary reviews. RNA 10, e1523, doi:10.1002/wrna.1523 (2019). [PubMed: 
30729694] 
2. Wan R, Bai R, Yan C, Lei J & Shi Y Structures of the Catalytically Activated Yeast Spliceosome 
Reveal the Mechanism of Branching. Cell, doi:10.1016/j.cell.2019.02.006 (2019).
3. De Conti L, Baralle M & Buratti E Exon and intron definition in pre-mRNA splicing. Wiley 
interdisciplinary reviews. RNA 4, 49–60, doi:10.1002/wrna.1140 (2013). [PubMed: 23044818] 
4. Berget SM Exon recognition in vertebrate splicing. J Biol Chem 270, 2411–2414 (1995). [PubMed: 
7852296] 
Li et al. Page 34
Nature. Author manuscript; available in PMC 2020 March 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
5. Sharma S, Kohlstaedt LA, Damianov A, Rio DC & Black DL Polypyrimidine tract binding protein 
controls the transition from exon definition to an intron defined spliceosome. Nat Struct Mol Biol 
15, 183–191, doi:10.1038/nsmb.1375 (2008). [PubMed: 18193060] 
6. Schneider M et al. Exon definition complexes contain the tri-snRNP and can be directly converted 
into B-like precatalytic splicing complexes. Mol Cell 38, 223–235, doi:10.1016/j.molcel.
2010.02.027 (2010). [PubMed: 20417601] 
7. Wang PL et al. Circular RNA is expressed across the eukaryotic tree of life. PLoS One 9, e90859, 
doi:10.1371/journal.pone.0090859 (2014). [PubMed: 24609083] 
8. Wilusz JEA 360 degrees view of circular RNAs: From biogenesis to functions. Wiley 
interdisciplinary reviews. RNA 9, e1478, doi:10.1002/wrna.1478 (2018). [PubMed: 29655315] 
9. Starke S et al. Exon circularization requires canonical splice signals. Cell Rep 10, 103–111, doi:
10.1016/j.celrep.2014.12.002 (2015). [PubMed: 25543144] 
10. Seraphin B, Kretzner L & Rosbash M A U1 snRNA:pre-mRNA base pairing interaction is required 
early in yeast spliceosome assembly but does not uniquely define the 5’ cleavage site. EMBO J 7, 
2533–2538 (1988). [PubMed: 3056718] 
11. Siliciano PG & Guthrie C 5’ splice site selection in yeast: genetic alterations in base-pairing with 
U1 reveal additional requirements. Genes Dev 2, 1258–1267 (1988). [PubMed: 3060402] 
12. Ruby SW & Abelson J An early hierarchic role of U1 small nuclear ribonucleoprotein in 
spliceosome assembly. Science 242, 1028–1035 (1988). [PubMed: 2973660] 
13. Abovich N & Rosbash M Cross-intron bridging interactions in the yeast commitment complex are 
conserved in mammals. Cell 89, 403–412 (1997). [PubMed: 9150140] 
14. Plaschka C, Lin PC, Charenton C & Nagai K Prespliceosome structure provides insights into 
spliceosome assembly and regulation. Nature 559, 419–422, doi:10.1038/s41586-018-0323-8 
(2018). [PubMed: 29995849] 
15. Bai R, Wan R, Yan C, Lei J & Shi Y Structures of the fully assembled Saccharomyces cerevisiae 
spliceosome before activation. Science, doi:10.1126/science.aau0325 (2018).
16. Lewis JD, Izaurralde E, Jarmolowski A, McGuigan C & Mattaj IW A nuclear cap-binding complex 
facilitates association of U1 snRNP with the cap-proximal 5’ splice site. Genes Dev 10, 1683–
1698 (1996). [PubMed: 8682298] 
17. Qiu ZR, Chico L, Chang J, Shuman S & Schwer B Genetic interactions of hypomorphic mutations 
in the m7G cap-binding pocket of yeast nuclear cap binding complex: an essential role for Cbc2 in 
meiosis via splicing of MER3 pre-mRNA. RNA 18, 1996–2011, doi:10.1261/rna.033746.112 
(2012). [PubMed: 23002122] 
18. Puig O, Gottschalk A, Fabrizio P & Seraphin B Interaction of the U1 snRNP with nonconserved 
intronic sequences affects 5’ splice site selection. Genes Dev 13, 569–580 (1999). [PubMed: 
10072385] 
19. Lesser CF & Guthrie C Mutational analysis of pre-mRNA splicing in Saccharomyces cerevisiae 
using a sensitive new reporter gene, CUP1. Genetics 133, 851–863 (1993). [PubMed: 8462846] 
20. Liu S et al. Structure of the yeast spliceosomal postcatalytic P complex. Science 358, 1278–1283, 
doi:10.1126/science.aar3462 (2017). [PubMed: 29146870] 
21. Lu M et al. Crystal structure of the three tandem FF domains of the transcription elongation 
regulator CA150. J Mol Biol 393, 397–408, doi:10.1016/j.jmb.2009.07.086 (2009). [PubMed: 
19660470] 
22. Liu J, Fan S, Lee CJ, Greenleaf AL & Zhou P Specific interaction of the transcription elongation 
regulator TCERG1 with RNA polymerase II requires simultaneous phosphorylation at Ser2, Ser5, 
and Ser7 within the carboxyl-terminal domain repeat. J Biol Chem 288, 10890–10901, doi:
10.1074/jbc.M113.460238 (2013). [PubMed: 23436654] 
23. Li X et al. CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative 
splicing. Nature communications 8, 1035, doi:10.1038/s41467-017-01241-9 (2017).
24. Gornemann J et al. Cotranscriptional spliceosome assembly and splicing are independent of the 
Prp40p WW domain. RNA 17, 2119–2129, doi:10.1261/rna.02646811 (2011). [PubMed: 
22020974] 
25. Ester C & Uetz P The FF domains of yeast U1 snRNP protein Prp40 mediate interactions with 
Luc7 and Snu71. BMC Biochem 9, 29, doi:10.1186/1471-2091-9-29 (2008). [PubMed: 19014439] 
Li et al. Page 35
Nature. Author manuscript; available in PMC 2020 March 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
26. Wiesner S, Stier G, Sattler M & Macias MJ Solution structure and ligand recognition of the WW 
domain pair of the yeast splicing factor Prp40. J Mol Biol 324, 807–822 (2002). [PubMed: 
12460579] 
27. Jacewicz A, Chico L, Smith P, Schwer B & Shuman S Structural basis for recognition of intron 
branchpoint RNA by yeast Msl5 and selective effects of interfacial mutations on splicing of yeast 
pre-mRNAs. RNA 21, 401–414, doi:10.1261/rna.048942.114 (2015). [PubMed: 25587180] 
28. Kappel K & Das R Sampling Native-like Structures of RNA-Protein Complexes through Rosetta 
Folding and Docking. Structure 27, 140–151 e145, doi:10.1016/j.str.2018.10.001 (2019). 
[PubMed: 30416038] 
29. Howe KJ, Kane CM & Ares M Jr. Perturbation of transcription elongation influences the fidelity of 
internal exon inclusion in Saccharomyces cerevisiae. RNA 9, 993–1006 (2003). [PubMed: 
12869710] 
30. Campodonico E & Schwer B ATP-dependent remodeling of the spliceosome: intragenic 
suppressors of release-defective mutants of Saccharomyces cerevisiae Prp22. Genetics 160, 407–
415 (2002). [PubMed: 11861548] 
31. Liang D et al. The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA 
Processing Machinery Is Limiting. Mol Cell 68, 940–954 e943, doi:10.1016/j.molcel.2017.10.034 
(2017). [PubMed: 29174924] 
32. Ragan C, Goodall GJ, Shirokikh NE & Preiss T Insights into the biogenesis and potential functions 
of exonic circular RNA. Scientific reports 9, 2048, doi:10.1038/s41598-018-37037-0 (2019). 
[PubMed: 30765711] 
33. Liang D & Wilusz JE Short intronic repeat sequences facilitate circular RNA production. Genes 
Dev 28, 2233–2247, doi:10.1101/gad.251926.114 (2014). [PubMed: 25281217] 
34. Jeck WR et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 
141–157, doi:10.1261/rna.035667.112 (2013). [PubMed: 23249747] 
35. Mokry M et al. Accurate SNP and mutation detection by targeted custom microarray-based 
genomic enrichment of short-fragment sequencing libraries. Nucleic Acids Res 38, e116, doi:
10.1093/nar/gkq072 (2010). [PubMed: 20164091] 
36. Spingola M, Grate L, Haussler D & Ares M Jr. Genome-wide bioinformatic and molecular analysis 
of introns in Saccharomyces cerevisiae. Rna 5, 221–234 (1999). [PubMed: 10024174] 
37. Li X et al. Comprehensive in vivo RNA-binding site analyses reveal a role of Prp8 in spliceosomal 
assembly. Nucleic Acids Res 41, 3805–3818, doi:10.1093/nar/gkt062 (2013). [PubMed: 
23393194] 
38. Abelson J et al. Conformational dynamics of single pre-mRNA molecules during in vitro splicing. 
Nat Struct Mol Biol 17, 504–512. [PubMed: 20305654] 
39. Carragher B et al. Leginon: an automated system for acquisition of images from vitreous ice 
specimens. J Struct Biol 132, 33–45, doi:10.1006/jsbi.2000.4314 (2000). [PubMed: 11121305] 
40. Zheng SQ, Palovcak E, Armache J-P, Cheng Y & Agard DA in bioRxiv (2016).
41. Rohou A & Grigorieff N CTFFIND4: Fast and accurate defocus estimation from electron 
micrographs. J Struct Biol 192, 216–221, doi:10.1016/j.jsb.2015.08.008 (2015). [PubMed: 
26278980] 
42. Scheres SH & Chen S Prevention of overfitting in cryo-EM structure determination. Nature 
methods 9, 853–854, doi:10.1038/nmeth.2115 (2012). [PubMed: 22842542] 
43. Chen S et al. High-resolution noise substitution to measure overfitting and validate resolution in 
3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–
35, doi:10.1016/j.ultramic.2013.06.004 (2013). [PubMed: 23872039] 
44. Rosenthal PB & Henderson R Optimal determination of particle orientation, absolute hand, and 
contrast loss in single-particle electron cryomicroscopy. J Mol Biol 333, 721–745 (2003). 
[PubMed: 14568533] 
45. Kucukelbir A, Sigworth FJ & Tagare HD Quantifying the local resolution of cryo-EM density 
maps. Nature methods 11, 63–65, doi:10.1038/nmeth.2727 (2014). [PubMed: 24213166] 
46. Pettersen EF et al. UCSF Chimera--a visualization system for exploratory research and analysis. 
Journal of computational chemistry 25, 1605–1612, doi:10.1002/jcc.20084 (2004). [PubMed: 
15264254] 
Li et al. Page 36
Nature. Author manuscript; available in PMC 2020 March 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
47. Emsley P, Lohkamp B, Scott WG & Cowtan K Features and development of Coot. Acta 
Crystallogr D Biol Crystallogr 66, 486–501, doi:10.1107/S0907444910007493 (2010). [PubMed: 
20383002] 
48. Keating KS & Pyle AM RCrane: semi-automated RNA model building. Acta Crystallogr D Biol 
Crystallogr 68, 985–995, doi:10.1107/S0907444912018549 (2012). [PubMed: 22868764] 
49. Chou FC, Sripakdeevong P, Dibrov SM, Hermann T & Das R Correcting pervasive errors in RNA 
crystallography through enumerative structure prediction. Nature methods 10, 74–76, doi:10.1038/
nmeth.2262 (2013). [PubMed: 23202432] 
50. Kappel K et al. De novo computational RNA modeling into cryo-EM maps of large 
ribonucleoprotein complexes. Nature methods 15, 947–954, doi:10.1038/s41592-018-0172-2 
(2018). [PubMed: 30377372] 
51. Adams PD et al. PHENIX: a comprehensive Python-based system for macromolecular structure 
solution. Acta Crystallogr D Biol Crystallogr 66, 213–221, doi:10.1107/S0907444909052925 
(2010). [PubMed: 20124702] 
52. Chen VB et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta 
Crystallogr D Biol Crystallogr 66, 12–21, doi:10.1107/S0907444909042073 (2010). [PubMed: 
20057044] 
53. Goddard TD et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. 
Protein Sci 27, 14–25, doi:10.1002/pro.3235 (2018). [PubMed: 28710774] 
54. Wisniewski JR, Zougman A, Nagaraj N & Mann M Universal sample preparation method for 
proteome analysis. Nature methods 6, 359–362, doi:10.1038/nmeth.1322 (2009). [PubMed: 
19377485] 
55. Grimm M, Zimniak T, Kahraman A & Herzog F xVis: a web server for the schematic visualization 
and interpretation of crosslink-derived spatial restraints. Nucleic Acids Res 43, W362–369, doi:
10.1093/nar/gkv463 (2015). [PubMed: 25956653] 
56. Seraphin B & Rosbash M Identification of functional U1 snRNA-pre-mRNA complexes committed 
to spliceosome assembly and splicing. Cell 59, 349–358 (1989). [PubMed: 2529976] 
57. Higuchi F et al. Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 36, 7253–7267, doi:
10.1523/JNEUROSCI.0319-16.2016 (2016). [PubMed: 27383599] 
58. Qin D, Huang L, Wlodaver A, Andrade J & Staley JP Sequencing of lariat termini in S. cerevisiae 
reveals 5’ splice sites, branch points, and novel splicing events. RNA 22, 237–253, doi:10.1261/
rna.052829.115 (2016). [PubMed: 26647463] 
Li et al. Page 37
Nature. Author manuscript; available in PMC 2020 March 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. In vitro assembled E complex is functional.
(a) The assembled E complex (with or without DNA oligo-directed RNase H treatment to 
cleave between the 5’ ss and BPS) is purified using the MS2 tag on pre-mRNA and its 
protein components shown. (b) Yeast splicing extract with or without U1 snRNA depletion 
is incubated with in vitro transcribed M3-Act1 or E complex assembled on M3-Act1 in the 
presence or absence of ATP or excess Act1-M3 (top gel). The splicing outcome is monitored 
using RT-PCR with primers located in the MS2 binding site region and exon 2 of M3-Act1. 
The middle and bottom gels demonstrate levels of U1 and U2 snRNA in each sample. 
Experiments in Fig. 1 were repeated two additional times with similar results. For all gel 
source data in this paper, see Supplementary Figure 1.
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Fig. 2. CryoEM structure of the E complex.
(a) The overall E complex structure. BPP/Mud2 are not modeled due to weak density, but 
their locations are indicated. (b) Ribbon diagrams of protein and RNA models immediately 
around the 5’ss. (c) Surface representation of proteins that are in close proximity to the 5’ ss 
(colored), other proteins (grey), and U1 snRNA (cyan). Pre-mRNA is shown in red and 
nucleotide positions relative to the 5’ ss are labeled (−1 and +1 denote the last nt of the exon 
and the first nt of the intron, respectively). (d) Secondary structure in pre-mRNA. Left: 
CryoEM density map (filtered to 6 Å) of the entire E complex showing density (in red 
dashed box) for the pre-mRNA double helix. Middle: Electrostatic potentials of the binding 
surface for the pre-mRNA double helix. Right: The binding surface formed by Prp39, Prp42, 
and U1C is shown in ribbon diagrams. Positively charged residues on Prp39 and Prp42 that 
interact with this double helix are shown in sticks. (e) Splicing efficiency of the WT and 
mutant Act1 intron (that disrupts the secondary structure in the 5’ ss to BPS region) in an 
Act1-Cup1 reporter plasmid, as evaluated by qRT-PCR. Dots represent three technical 
replicates. This experiment was repeated two additional times with similar results. (f) 
Surface representation of proteins that interact or possibly interact with Prp40 are shown in 
different colors. Locations of proteins or protein domains not modeled due to weak densities 
are indicated by various shapes. Transparent grey areas are 8 Å low-pass filtered densities 
showing likely contacts between Prp40 and U1-70K. Red dashed lines represent 
hypothetical paths of the pre-mRNA.
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Fig. 3. A unified model for intron definition, exon definition, and back-splicing.
(a) Structures of the E, A, and pre-B complexes are shown in surface representations with 
U1, U2, and tri-snRNPs in different colors, illustrating the canonical assembly pathway 
across an intron. Pre-mRNA is shown in red with an arrow indicating the 5’ to 3’ direction. 
Red dashed line indicates the hypothetical path of intron connecting the 5’ ss and 
downstream BPS. Vertical dash lines are drawn to denote the orientation of U1 snRNP and 
U2 SF3b in the A complex. In the pre-B complex, the orientation of U1 snRNP remains the 
same but that of U2 SF3b is tilted about 30°. (b) The same spliceosomal E and A complexes 
as in (A) can assemble across an exon, but cannot form the pre-B complex on short exons 
due to steric hindrance. Blue dashed line indicates the hypothetical path of exon connecting 
the BPS and downstream 5’ ss. (c) Same as (b), but with a long exon (green dashed line), 
illustrating that the EDC on long exons can catalyze back-splicing. (d) A schematic 
representation showing how the EDC on a long exon carries out back-splicing and generates 
circular RNA through the same transesterification reactions used by canonical splicing.
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Fig. 4. Exon definition occurs in yeast.
(a) A plasmid containing the WT DYN2 gene or various mutants was transformed into a 
DYN2 KO strain. The splicing efficiency of intron 1 and 2 were evaluated using qRT-PCR 
with primers specific for intron 1 or intron 2 (indicated by arrows in the schematics under 
the bar diagram) normalized to total mRNA. Dots represent three technical replicates. (b) 
RT-PCR of RNA extracted from yeast strain carrying indicated plasmids, using primers 
located in exons 1 and 3 of Dyn2. A schematic of the splicing product and their expected 
sizes are shown on the right side of the gel. RT-PCR products using primers in exon 3 
(bottom gel) serve as an internal quality control of the samples. Experiments in Fig. 4 were 
repeated two additional times with similar results.
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Fig. 5. The EDC catalyzes back-splicing and produces circRNA.
(a) RT-PCR of RNA isolated from spliceosome purified from the Prp22H606A yeast strain 
(indicated by “S”) and PCR using yeast genomic DNA (indicated by “g”, as negative 
controls) for single intron gene RPP1B and multi-intronic genes EFM5 and HMRA1 
demonstrate the presence of ligated exons (lane 1), lariat (lane 3), T-branches (lanes 5 and 7) 
and circRNA (lanes 9-10). Primer positions are indicated as arrows in the schematic 
diagrams below the gel. All images in Fig. 5 are RT-PCR/PCR products on agarose gel with 
EtBr staining. (b) RT-PCR of RNA extracted from WT or EFM5 KO strain carrying 
indicated plasmid, with or without RNaseR treatment, using primers shown in the schematic 
diagrams below the gel. Numbers 101 and 63 designate exon lengths. “mut” represents 
mutant. Lanes 1-7 indicate all EFM5 constructs are transcribed. (c) IEI-101-M3 (3xMS2 at 
the 3’ end) RNA or E complex assembled on IEI-101-M3 was incubated with splicing 
extract with or without U1 snRNA depletion in the absence or presence of 30-fold excess 
competing IEI-101 RNA. CircRNA products were monitored the same way as (b). 
Competing IEI-101 was modified to remove the primer binding sites so it is invisible in the 
RT-PCR reaction. Experiments in (a), (b), and (c) were repeated one, two, and two additional 
times, respectively, with similar results.
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